Drug intelligence / Profile preview

FR247581

Development stage
Unknown
Modality
Small Molecules
01

Overview

FR247581 is a synthetic small molecule compound containing an imidazone core and a naphthyloxyethyl side chain. It is primarily known as an experimental agent and has been referenced in chemical databases but lacks detailed published information on its mechanism of action or clinical development. The compound's structure suggests potential biological activity related to the imidazone scaffold, which can be associated with enzyme inhibition or receptor modulation; however, no specific pharmacological target or therapeutic indication has been established in the literature[6][10][7]. It is not approved for any medical use.

Other names
1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE1-((1R,2S)-2-Hydroxy-1-(2-(2-naphthyloxy)ethyl)propyl)-1H-imidazone-4-carboxamide3-(4-Carbamoyl-1H-imidazol-1-yl)-1,3,4-trideoxy-5-O-(2-naphthalenyl)-D‑erythro-pentitol

Beyond the preview

Go deeper on FR247581.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FR247581.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call